NYSE: ADCTAdc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?
Insider buying vs selling
Have Adc Therapeutics Sa insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ADCT insiders and whales buy or sell their stock.
ADCT Shareholders
What type of owners hold Adc Therapeutics Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Redmile Group LLC | 33.76% | 27,864,257 | $133.19M | Insider |
| Redmile Group LLC | 18.57% | 15,328,317 | $73.27M | Institution |
| Prosight Management LP | 7.84% | 6,471,800 | $30.94M | Institution |
| Millennium Management LLC | 3.24% | 2,672,810 | $12.78M | Institution |
| Citadel Advisors LLC | 2.25% | 1,853,412 | $8.86M | Institution |
| Bank Of America Corp | 1.85% | 1,525,741 | $7.29M | Institution |
| Goldman Sachs Group Inc | 1.77% | 1,459,514 | $6.98M | Institution |
| Ameet Mallik | 1.45% | 1,197,079 | $5.72M | Insider |
| Affinity Asset Advisors LLC | 1.23% | 1,013,540 | $4.84M | Institution |
| Vantage Consulting Group Inc | 1.03% | 850,737 | $4.07M | Institution |
ADCT vs Biotech Stocks
Adc Therapeutics Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.